Epidermal Growth Factor Inhibitor-induced Cutaneous Toxicity Improves with Moisturizers
نویسندگان
چکیده
منابع مشابه
Nursing management of epidermal growth factor receptor inhibitor-induced toxicities.
New drug technologies can pose a challenge for nurses, whether it is by educating patients about potential side effects or by helping them deal with sequelae for which there has been little research. Epidermal growth factor receptor (EGFR) inhibitors are new, targeted cancer therapies that are being prescribed with more frequency. Common side effects of EGFR inhibitors include skin rash and dia...
متن کاملPsychosocial impact of cutaneous toxicities associated with epidermal growth factor receptor-inhibitor treatment.
Epidermal growth factor receptor inhibitors (EGFRIs) are an increasingly important class of anticancer agents. Cutaneous toxicities, the most common adverse effects of EGFRI therapy, require dose modification or treatment cessation when moderate or severe and may compromise treatment compliance. To date, assessment has focused on physical symptoms associated with cutaneous toxicities; however, ...
متن کاملEpidermal Growth Factor-Induced Hydrolysis
The enzymatic pathways for formation of 1,2-diradylglyceride in response to epidermal growth factor in human dermal fibroblasts have been investigated. 1,2-Diradylglyceride mass was elevated 2-fold within one minute of addition of EGF. Maximal accumulation (4-fold) occurred at 5 minutes. Since both diacyl and ether-linked diglyceride species occur naturally and may accumulate following agonist ...
متن کاملSuccessful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
EGFR: epidermal growth factor receptor NSCLC: nonesmall cell lung cancer INTRODUCTION Both scarring and nonscarring alopecias have been described with the long-term use of epidermal growth factor receptor (EGFR) inhibitors. Current treatments revolve around anti-inflammatory agents such as topical corticosteroid ointments, creams, and intralesional injections to reduce follicular inflammation. ...
متن کاملSuccessful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
Epidermal growth factor receptor (EGFR) inhibitors are increasingly used for cancer treatment, but commonly carry dermatologic side effects. Periungual inflammation is a particularly painful condition that additionally worsens quality of life. In this paper, we report 3 cases of successful treatment of periungual inflammation induced by 3 different EGFR inhibitors (gefitinib, erlotinib, and cet...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Trends in Immunotherapy
سال: 2020
ISSN: 2573-5985
DOI: 10.24294/ti.v4.i1.1187